. Author manuscript; available in PMC: 2018 Aug 1.

Published in final edited form as: Acta Neuropathol. 2017 May 9;134(2):171–186. doi: 10.1007/s00401-017-1717-7

Table 2.

– Prevalence of Mixed Pathologies in ROS/MAP

Pathology	Clinical Diagnosis
Pathology	No Cognitive Impairment (n=360)	Mild Cognitive Impairment (n=271)	Probable AD (n=447)
No Vascular or Neurodegenerative	50 (13.89%)	12 (4.43%)	4 (0.89%)
Vascular only	102 (28.33%)	57 (21.03%)	22 (4.92%)
Other Degenerative only	14 (3.89%)	8 (2.95%)	6 (1.34%)
Other Degenerative + Vascular (no AD)	41 (11.39%)	28 (10.33%)	35 (7.83%)
AD only	30 (8.33%)	20 (7.38%)	14 (3.13%)
AD + Vascular	75 (20.83%)	65 (23.99%)	122 (27.29%)
AD + Other Degenerative	6 (1.67%)	17 (6.27%)	34 (7.61%)
AD + Other Degenerative + Vascular	42 (11.67%)	64 (23.62%)	210 (46.98%)